generics News

US Tariffs Threaten Indian Pharma: A Deep Dive into the Looming Crisis and Its Global Impact

The Indian pharmaceutical industry faces uncertainty as potential US tariffs threaten to raise drug prices, disrupt supply chains, and impact exporters. With $9 billion at stake, t...

Biocon's Strategic Leap: Dominating Generics and Biosimilars for Global Growth

Biocon is focusing on new product launches in generics and biosimilars to fuel its expansion, leveraging the Viatris acquisition for an integrated biosimilars enterprise model. The...